JP Morgan Chase’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-40,000
Closed -$186K 7452
2024
Q4
$186K Buy
+40,000
New +$220K ﹤0.01% 5505

Other funds holding GDRX

JP Morgan Chase's GDRX Position: Q1 2026 in Review

JP Morgan Chase held its GoodRx Holdings (GDRX) position steady in Q1 2026 at 1,000 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #7024.

JP Morgan Chase first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $49.5M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • JP Morgan Chase held 1,000 shares of GoodRx Holdings worth $1.91K as of Q1 2026.
  • JP Morgan Chase left its GoodRx Holdings share count unchanged in Q1 2026.
  • GoodRx Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7024 holding.
  • JP Morgan Chase first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • JP Morgan Chase's GoodRx Holdings position peaked at $49.5M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.